Osteotronix Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Osteotronix General Information

Description

Developer of magnetic resonance-based diagnostic software designed to detect early signs of spinal diseases and conditions. The company's platform works as an add-on to existing magnetic resonance imaging hardware facilitating images to be captured in lesser time, enabling physicians to view in-vivo characterizations and detect organ fibrosis, cancer, and bone disease.

Contact Information

Website
www.osteotronix.org
Formerly Known As
Acuitas Medical
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • The Life Sciences Hub 3
  • Assembly Square
  • Cardiff CF10 4PL
  • Wales, United Kingdom
Primary Industry
Decision/Risk Analysis
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • The Life Sciences Hub 3
  • Assembly Square
  • Cardiff CF10 4PL
  • Wales, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Osteotronix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 24-Nov-2017 Completed Out of Business
7. Later Stage VC 30-Mar-2012 Completed Generating Revenue
6. Later Stage VC 22-Jun-2011 Completed Startup
5. Early Stage VC 22-Mar-2011 Completed Startup
4. Angel (individual) 08-Apr-2010 Completed Startup
3. Angel (individual) 09-Feb-2009 Completed Startup
2. Angel (individual) 27-Mar-2007 $483K $483K Completed Startup
1. Grant $2.08M Completed Startup
To view Osteotronix’s complete valuation and funding history, request access »

Osteotronix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary A
Preference Shares
Preference Shares
Ordinary A 575 $0.158209 $316.42 $316.42 1x $316.42 2.7%
Ordinary A 1,832 $0.158209 $214.1 $214.1 1x $214.1 8.59%
To view Osteotronix’s complete cap table history, request access »

Osteotronix Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Osteotronix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2020049237-A Method of assessing data quality of fine structure analysis data Pending 30-May-2014
JP-2017516590-A Method to evaluate and improve the data quality of microstructure analysis data Active 30-May-2014
EP-2756323-A1 Magnetic resonance based method for assessing alzheimer's disease and related pathologies Inactive 13-Sep-2011
GB-2503609-A Representation of spatial-frequency data as a map Active 07-Mar-2011
GB-201317680-D0 Representation of spatial-frequency data as a map Active 07-Mar-2011 G01N21/255
To view Osteotronix’s complete patent history, request access »

Ready to get started?

Request a free trial

Osteotronix FAQs

  • When was Osteotronix founded?

    Osteotronix was founded in 2006.

  • Where is Osteotronix headquartered?

    Osteotronix is headquartered in Cardiff, United Kingdom.

  • What industry is Osteotronix in?

    Osteotronix’s primary industry is Decision/Risk Analysis.

  • Is Osteotronix a private or public company?

    Osteotronix is a Private company.

  • What is Osteotronix’s current revenue?

    The current revenue for Osteotronix is .

  • How much funding has Osteotronix raised over time?

    Osteotronix has raised $5.46M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »